Literature DB >> 27751935

Health-Related Quality of Life among Older Related Hematopoietic Stem Cell Donors (>60 Years) Is Equivalent to That of Younger Related Donors (18 to 60 Years): A Related Donor Safety Study.

Galen E Switzer1, Jessica Bruce2, Deidre M Kiefer3, Hati Kobusingye3, Rebecca Drexler3, RaeAnne M Besser3, Dennis L Confer3, Mary M Horowitz4, Roberta J King3, Bronwen E Shaw4, Marcie Riches5, Brandon Hayes-Lattin6, Michael Linenberger7, Brian Bolwell8, Scott D Rowley9, Mark R Litzow10, Michael A Pulsipher11.   

Abstract

The increasing number of older adults with blood-related disorders and the introduction of reduced-intensity conditioning regimens has led to increases in hematopoietic stem cell (HSC) transplantation among older adults and a corresponding increase in the age of siblings who donate HSCs to these patients. Data regarding the donation-related experiences of older donors are lacking. The Related Donor Safety Study aimed to examine/compare health-related quality of life (HRQoL) of older versus younger HSC donors. Sixty peripheral blood stem cell (PBSC) donors ages 18 to 60 years and 104 PBSC donors age >60 years completed validated questionnaires before donation and 4 weeks and 1 year after donation. Before donation, older donors had poorer general physical health (t = -3.27; P = .001) but better mental health (t = 2.11; P < .05). There were no age differences in multiple other donation-related factors. At 4 weeks after donation, there were no group differences in general physical/mental health, but older donors were less likely to report donation-related pain (t = -2.26; P < .05) and concerns (t = -3.38; P = .001). At both 4 weeks and 1 year after donation, there were no significant differences in the percentage of each age group feeling physically back to normal or in the number of days it took donors to feel completely well. There was no evidence that increasing age within the older donor group was associated with poorer donation-related HRQoL. Taken together, these data support the current practice of HSC donation by sibling donors above age 60, providing no evidence of worsening HRQoL up to 1 year after donation in individuals up to age 76.
Copyright © 2017 The American Society for Blood and Marrow Transplantation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  HSC donor health-related quality of life (HRQoL); Hematopoietic stem cell (HSC) donation; Related donation

Mesh:

Year:  2016        PMID: 27751935      PMCID: PMC5182103          DOI: 10.1016/j.bbmt.2016.10.008

Source DB:  PubMed          Journal:  Biol Blood Marrow Transplant        ISSN: 1083-8791            Impact factor:   5.742


  19 in total

1.  Donating stimulated peripheral blood stem cells vs bone marrow: do donors experience the procedures differently?

Authors:  G E Switzer; J M Goycoolea; M A Dew; E C Graeff; J Hegland
Journal:  Bone Marrow Transplant       Date:  2001-05       Impact factor: 5.483

2.  The impact of improved JACIE standards on the care of related BM and PBSC donors.

Authors:  C Anthias; M E Ethell; M N Potter; A Madrigal; B E Shaw
Journal:  Bone Marrow Transplant       Date:  2014-11-10       Impact factor: 5.483

3.  Impact of donor age on outcome after allogeneic hematopoietic cell transplantation.

Authors:  Andrew R Rezvani; Barry E Storer; Katherine A Guthrie; H Gary Schoch; David G Maloney; Brenda M Sandmaier; Rainer Storb
Journal:  Biol Blood Marrow Transplant       Date:  2014-09-30       Impact factor: 5.742

4.  Efficacy and safety of peripheral blood stem cell collection in elderly donors; does age interfere?

Authors:  Daniel Lysák; Zdeněk Kořístek; Zdeňka Gašová; Iva Skoumalová; Pavel Jindra
Journal:  J Clin Apher       Date:  2010-10-27       Impact factor: 2.821

5.  Older patients/older donors: choosing wisely.

Authors:  Andrew S Artz
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2013

6.  Unrelated adult stem cell donor medical suitability: recommendations from the World Marrow Donor Association Clinical Working Group Committee.

Authors:  R N Lown; J Philippe; W Navarro; S M van Walraven; L Philips-Johnson; M Fechter; R Pawson; M Bengtsson; M Beksac; S Field; H Yang; B E Shaw
Journal:  Bone Marrow Transplant       Date:  2014-04-07       Impact factor: 5.483

7.  Donor safety: the role of the WMDA in ensuring the safety of volunteer unrelated donors: clinical and ethical considerations.

Authors:  B E Shaw; L Ball; M Beksac; M Bengtsson; D Confer; S Diler; M Fechter; H Greinix; M Koh; S Lee; G Nicoloso-De-Faveri; J Philippe; S Pollichieni; M Pulsipher; A Schmidt; E Yang; A-M van Walraven
Journal:  Bone Marrow Transplant       Date:  2010-02-22       Impact factor: 5.483

8.  Influence of related donor age on outcomes after peripheral blood stem cell transplantation.

Authors:  Elie M Richa; Rangesh Kunnavakkam; Lucy A Godley; Justin Kline; Olatoyosi Odenike; Richard A Larson; Vu Nguyen; Wendy Stock; Amittha Wickrema; Koen Van Besien; Andrew S Artz
Journal:  Cytotherapy       Date:  2012-05-02       Impact factor: 5.414

9.  Donor, recipient, and transplant characteristics as risk factors after unrelated donor PBSC transplantation: beneficial effects of higher CD34+ cell dose.

Authors:  Michael A Pulsipher; Pintip Chitphakdithai; Brent R Logan; Susan F Leitman; Paolo Anderlini; John P Klein; Mary M Horowitz; John P Miller; Roberta J King; Dennis L Confer
Journal:  Blood       Date:  2009-07-16       Impact factor: 22.113

10.  Phase II Study of Allogeneic Transplantation for Older Patients With Acute Myeloid Leukemia in First Complete Remission Using a Reduced-Intensity Conditioning Regimen: Results From Cancer and Leukemia Group B 100103 (Alliance for Clinical Trials in Oncology)/Blood and Marrow Transplant Clinical Trial Network 0502.

Authors:  Steven M Devine; Kouros Owzar; William Blum; Flora Mulkey; Richard M Stone; Jack W Hsu; Richard E Champlin; Yi-Bin Chen; Ravi Vij; James Slack; Robert J Soiffer; Richard A Larson; Thomas C Shea; Vera Hars; Alexander B Sibley; Sergio Giralt; Shelly Carter; Mary M Horowitz; Charles Linker; Edwin P Alyea
Journal:  J Clin Oncol       Date:  2015-11-02       Impact factor: 44.544

View more
  4 in total

1.  Plerixafor alone for the mobilization and transplantation of HLA-matched sibling donor hematopoietic stem cells.

Authors:  Yi-Bin Chen; Jennifer Le-Rademacher; Ruta Brazauskas; Deidre M Kiefer; Mehdi Hamadani; John F DiPersio; Mark R Litzow; Michael Craig; Mitchell E Horwitz; Andrew S Artz; Brian L McClune; Hugo F Fernandez; Hien Kim Duong; Hati Kobusingye; Mandi Proue; Rebecca J Drexler; Mary M Horowitz; Bronwen E Shaw; John P Miller; Sakura Hosoba; Edmund K Waller; Steven M Devine
Journal:  Blood Adv       Date:  2019-03-26

2.  Health-Related Quality-of-Life Comparison of Adult Related and Unrelated HSC Donors: An RDSafe Study.

Authors:  Galen E Switzer; Jessica G Bruce; Deidre M Kiefer; Hati Kobusingye; Kaleab Z Abebe; Rebecca Drexler; RaeAnne M Besser; Dennis L Confer; Mary M Horowitz; Roberta J King; Bronwen E Shaw; Marcie Riches; Brandon Hayes-Lattin; Michael Linenberger; Brian Bolwell; Scott D Rowley; Mark R Litzow; Michael A Pulsipher
Journal:  Biol Blood Marrow Transplant       Date:  2020-08-21       Impact factor: 5.742

3.  Effect of Aging and Predonation Comorbidities on the Related Peripheral Blood Stem Cell Donor Experience: Report from the Related Donor Safety Study.

Authors:  Michael A Pulsipher; Brent R Logan; Pintip Chitphakdithai; Deidre M Kiefer; Marcie L Riches; J Douglas Rizzo; Paolo Anderlini; Susan F Leitman; James W Varni; Hati Kobusingye; RaeAnne M Besser; John P Miller; Rebecca J Drexler; Aly Abdel-Mageed; Ibrahim A Ahmed; Luke P Akard; Andrew S Artz; Edward D Ball; Ruthee-Lu Bayer; Carolyn Bigelow; Brian J Bolwell; E Randolph Broun; Nancy J Bunin; David C Delgado; Katharine Duckworth; Christopher C Dvorak; Theresa E Hahn; Ann E Haight; Parameswaran N Hari; Brandon M Hayes-Lattin; David A Jacobsohn; Ann A Jakubowski; Kimberly A Kasow; Hillard M Lazarus; Jane L Liesveld; Michael Linenberger; Mark R Litzow; Walter Longo; Margarida Magalhaes-Silverman; John M McCarty; Joseph P McGuirk; Shahram Mori; Vinod K Prasad; Scott D Rowley; Witold B Rybka; Indira Sahdev; Jeffrey R Schriber; George B Selby; Paul J Shaughnessy; Shalini Shenoy; Thomas Spitzer; William T Tse; Joseph P Uberti; Madhuri Vusirikala; Edmund K Waller; Daniel J Weisdorf; Gregory A Yanik; Willis H Navarro; Mary M Horowitz; Galen E Switzer; Bronwen E Shaw; Dennis L Confer
Journal:  Biol Blood Marrow Transplant       Date:  2018-11-10       Impact factor: 5.742

4.  Related peripheral blood stem cell donors experience more severe symptoms and less complete recovery at one year compared to unrelated donors.

Authors:  Michael A Pulsipher; Brent R Logan; Deidre M Kiefer; Pintip Chitphakdithai; Marcie L Riches; J Douglas Rizzo; Paolo Anderlini; O'Susan F Leitman; Hati Kobusingye; RaeAnne M Besser; John P Miller; Rebecca J Drexler; Aly Abdel-Mageed; Ibrahim A Ahmed; Luke P Akard; Andrew S Artz; Edward D Ball; Ruthee-Lu Bayer; Carolyn Bigelow; Brian J Bolwell; E Randolph Broun; David C Delgado; Katharine Duckworth; Christopher C Dvorak; Theresa E Hahn; Ann E Haight; Parameswaran N Hari; Brandon M Hayes-Lattin; David A Jacobsohn; Ann A Jakubowski; Kimberly A Kasow; Hillard M Lazarus; Jane L Liesveld; Michael Linenberger; Mark R Litzow; Walter Longo; Margarida Magalhaes-Silverman; John M McCarty; Joseph P McGuirk; Shahram Mori; Vinod Parameswaran; Vinod K Prasad; Scott D Rowley; Witold B Rybka; Indira Sahdev; Jeffrey R Schriber; George B Selby; Paul J Shaughnessy; Shalini Shenoy; Thomas Spitzer; William T Tse; Joseph P Uberti; Madhuri Vusirikala; Edmund K Waller; Daniel J Weisdorf; Gregory A Yanik; Willis H Navarro; Mary M Horowitz; Galen E Switzer; Dennis L Confer; Bronwen E Shaw
Journal:  Haematologica       Date:  2018-10-31       Impact factor: 9.941

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.